Clinical usage of ischemic tolerance-where are its limits?

Area of Science:

• Physiology
• Medicine
• Biochemistry

Background:

• Ischemic tolerance is a conserved biological defense mechanism observed across organisms.
• Experimental studies demonstrate its effectiveness, yet clinical applications remain largely unproven.
• Existing clinical data on ischemic tolerance is often ambiguous and unconvincing.

Purpose of the Study:

• To comprehensively review the clinical applicability of ischemic tolerance.
• To analyze the reasons behind discrepancies between experimental and clinical findings.
• To provide insights into the potential clinical use of ischemic tolerance for various patient groups.

Main Methods:

• Literature review of experimental and clinical studies on ischemic tolerance.
• Analysis of factors contributing to the variability in clinical outcomes.
• Synthesis of evidence to identify potential therapeutic strategies.

Main Results:

• Significant gap identified between robust experimental evidence and limited clinical validation of ischemic tolerance.
• Several factors, including patient heterogeneity and protocol variations, contribute to inconsistent clinical results.
• Potential clinical benefits are suggested in specific patient populations, warranting further investigation.

Conclusions:

• The clinical translation of ischemic tolerance faces challenges due to methodological and biological complexities.
• Further well-designed clinical trials are necessary to establish the efficacy and safety of ischemic tolerance interventions.
• Targeted application in specific patient groups may unlock the therapeutic potential of this natural defense mechanism.